KSR诉泰利福公司案后的药品专利生命周期管理 - Suppr

Suppr

超能文献

Pharmaceutical patent life-cycle management after KSR v. Teleflex.

作者信息

Furrow Michael Enzo

机构信息

Fitzpatrick, Cella, Harper & Scinto, New York, New York, USA.

出版信息

Food Drug Law J. 2008;63(1):275-320.

PMID:18561462

Abstract

摘要

相似文献

Pharmaceutical patent life-cycle management after KSR v. Teleflex.

Food Drug Law J. 2008;63(1):275-320.

Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.

Nat Biotechnol. 2007 Oct;25(10):1105-6. doi: 10.1038/nbt1007-1105.

Sublicense or supply agreement? Supreme Court of Canada interpretation benefits generic pharmaceutical industry.

Food Drug Law J. 1999;54(1):73-91.

Biotech patents-business as usual?

Nat Biotechnol. 2008 Dec;26(12):1326. doi: 10.1038/nbt1208-1326.

Using market-exclusivity incentives to promote pharmaceutical innovation.

N Engl J Med. 2010 Nov 4;363(19):1855-62. doi: 10.1056/NEJMhle1002961.

US courts narrow patent exemptions.

Nat Biotechnol. 2003 Aug;21(8):834. doi: 10.1038/nbt0803-834.

Patent fight sparks biological warfare in the drug industry.

Fortune. 2000 Jul 24;142(3):40, 42.

"Ganske" threatens biotechnology patents worldwide.

Nat Biotechnol. 1997 Feb;15(2):121. doi: 10.1038/nbt0297-121a.

Enforcing pharmaceutical and biotech patent rights in China.

Nat Biotechnol. 2008 Nov;26(11):1235-40. doi: 10.1038/nbt1108-1235.

The application of the patent laws to the drug approval process.

Food Drug Law J. 1997;52(4):345-55.

引用本文的文献

Polymorphs and prodrugs and salts (oh my!): an empirical analysis of "secondary" pharmaceutical patents.

PLoS One. 2012;7(12):e49470. doi: 10.1371/journal.pone.0049470. Epub 2012 Dec 5.

Sex, drugs and gender roles: mapping the use of sex and gender based analysis in pharmaceutical policy research.

Int J Equity Health. 2010 Nov 19;9:26. doi: 10.1186/1475-9276-9-26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Pharmaceutical patent life-cycle management after KSR v. Teleflex.

作者信息

Furrow Michael Enzo

机构信息

Fitzpatrick, Cella, Harper & Scinto, New York, New York, USA.

出版信息

Food Drug Law J. 2008;63(1):275-320.

PMID:18561462

Abstract

摘要

相似文献

Pharmaceutical patent life-cycle management after KSR v. Teleflex.

Food Drug Law J. 2008;63(1):275-320.

Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.

Nat Biotechnol. 2007 Oct;25(10):1105-6. doi: 10.1038/nbt1007-1105.

Sublicense or supply agreement? Supreme Court of Canada interpretation benefits generic pharmaceutical industry.

Food Drug Law J. 1999;54(1):73-91.

Biotech patents-business as usual?

Nat Biotechnol. 2008 Dec;26(12):1326. doi: 10.1038/nbt1208-1326.

Using market-exclusivity incentives to promote pharmaceutical innovation.

N Engl J Med. 2010 Nov 4;363(19):1855-62. doi: 10.1056/NEJMhle1002961.

US courts narrow patent exemptions.

Nat Biotechnol. 2003 Aug;21(8):834. doi: 10.1038/nbt0803-834.

Patent fight sparks biological warfare in the drug industry.

Fortune. 2000 Jul 24;142(3):40, 42.

"Ganske" threatens biotechnology patents worldwide.

Nat Biotechnol. 1997 Feb;15(2):121. doi: 10.1038/nbt0297-121a.

Enforcing pharmaceutical and biotech patent rights in China.

Nat Biotechnol. 2008 Nov;26(11):1235-40. doi: 10.1038/nbt1108-1235.

The application of the patent laws to the drug approval process.

Food Drug Law J. 1997;52(4):345-55.

引用本文的文献

Polymorphs and prodrugs and salts (oh my!): an empirical analysis of "secondary" pharmaceutical patents.

PLoS One. 2012;7(12):e49470. doi: 10.1371/journal.pone.0049470. Epub 2012 Dec 5.

Sex, drugs and gender roles: mapping the use of sex and gender based analysis in pharmaceutical policy research.

Int J Equity Health. 2010 Nov 19;9:26. doi: 10.1186/1475-9276-9-26.